2017
DOI: 10.1016/j.jaci.2017.05.017
|View full text |Cite
|
Sign up to set email alerts
|

Flow cytometric measurement of STAT1 and STAT3 phosphorylation in CD4 + and CD8 + T cells—clinical applications in primary immunodeficiency diagnostics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
10
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 11 publications
1
10
0
Order By: Relevance
“…STAT1 (pSTAT1) in addition to genetic testing and western blotting [5,6]. Here, we report a case of GOF STAT1 mutation in a patient diagnosed with AD-CMC by whole-exome sequencing and present the results of FCM, which are concordant with the sequencing results.…”
supporting
confidence: 53%
See 2 more Smart Citations
“…STAT1 (pSTAT1) in addition to genetic testing and western blotting [5,6]. Here, we report a case of GOF STAT1 mutation in a patient diagnosed with AD-CMC by whole-exome sequencing and present the results of FCM, which are concordant with the sequencing results.…”
supporting
confidence: 53%
“…Compared with the normal control group, the patient showed a significant expression of pSTAT1 (greater than two-fold SI) and a decreased reduction rate in response to the inhibitor. Although it is dif cult to determine the cut-off value for MFI or SI for the diagnosis of AD-CMC because of the limited number of pSTAT1 measurements performed using FCM worldwide, we suggest that FCM may be used as a simple and fast supplementary diagnostic tool for the GOF STAT1 mutations [5]. In addition to the potential of FCM as a diagnostic tool, FCM-based phosphorylation assays may be useful for monitoring treatment response in patients harboring a GOF or loss-of-function STAT1 mutations [5,18].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…To investigate for phosphorylation defects in STAT1 and STAT3, PBMCs from SLT patients ( n = 13) were isolated and cells were stimulated for 15 min with IL-6 (100 ng/ml), IL-21 (100 ng/ml), and IFNα (11,500 U/ml; R&D Systems, cat#11101-1) according to previously described diagnostic protocols 71 , 72 . Cells were fixed immediately (Cytofix Fixation Buffer; BD Biosciences, cat#554655), permeabilised (Phosflow Perm Buffer III; BD Biosciences, cat#558050), and stained for CD4 (CD4-FITC), pSTAT1 (STAT1 pY701—Alexa647; BD Biosciences, cat#612597) and pSTAT3 (STAT3 pY705 – PE; BD Biosciences, cat#612569).…”
Section: Methodsmentioning
confidence: 99%
“…In the study of PID patients, it is a limitation since it is usual that not all cell lineages are present; (B) choosing the correct recombinant cytokine is crucial as cytokine receptors are expressed differently in distinct lymphocyte lineages; (C) and selecting the appropriate antibodies against the STAT phosphorylation sites [30]. These studies can also be performed by WB, which is a very sensitive but more time-consuming technique and delays results [38].…”
Section: Functional Analysis Studying Stat Phosphorylationmentioning
confidence: 99%